AK

Ashok Kumar Tiwary

Director Director DIN 03333827
DIN 03333827 First appointment Dec 2010 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2010
Shareholding value •••• Premium profile

About Ashok Kumar Tiwary

Data last updated:

Ashok Kumar Tiwary was a Director at Stardom Pharmaceuticals Private Limited (2010–2021) and Director at Avison Pharmaceuticals Private Limited (2014–2015). The companies operate in Pharma.

DIN 03333827
Primary Designation Director
Industry Pharma
First Appointment 14 Dec 2010

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 Dec 20102010₹89.6 Lakh (FY 2025)Active
Director08 Oct 20142014₹15.33 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Stardom Pharmaceuticals Private Limited
Avison Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ashok Kumar Tiwary

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashok Kumar Tiwary

Ashok Kumar Tiwary was first appointed on 14 Dec 2010 as Director at Stardom Pharmaceuticals Private Limited. The most recent appointment on record is 08 Oct 2014 at Avison Pharmaceuticals Private Limited.

Ashok Kumar Tiwary held 2 earlier board appointments: Stardom Pharmaceuticals Private Limited (Director, 14 Dec 2010 to 03 Dec 2021); Avison Pharmaceuticals Private Limited (Director, 08 Oct 2014 to 17 Jan 2015).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available